3-Indolepropionic acid (Standard)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


3-Indolepropionic acid (Standard)
Description:
3-Indolepropionic acid (Standard) is the analytical standard of 3-Indolepropionic acid. This product is intended for research and analytical applications. 3-Indolepropionic acid is shown to be a powerful antioxidant and has potential in the treatment for Alzheimer’s disease. In Vitro: 3-Indolepropionic acid is shown to be a powerful antioxidant and has potential in the treatment for Alzheimer’s disease[1]. 3-Indolepropionic acid is a more potent scavenger of hydroxyl radicals than melatonin. Similar to melatonin but unlike other antioxidants, 3-Indolepropionic acid scavenges radicals without subsequently generating reactive and pro-oxidant intermediate compounds[2]. It is also suggested that indolepropionic acid, a gut microbiota-produced metabolite, is a potential biomarker for the development of type 2 diabetes (T2D) that may mediate its protective effect by preservation of β-cell function[3].Product Name Alternative:
Indole-3-propionic acid (Standard) ; 3-IPA (Standard)UNSPSC:
12352005Target:
Endogenous Metabolite; Reactive Oxygen Species (ROS) ; Reference StandardsType:
Reference StandardsRelated Pathways:
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; OthersApplications:
Metabolism-protein/nucleotide metabolismField of Research:
Metabolic Disease; Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/3-indolepropionic-acid-standard.htmlPurity:
99.97Smiles:
C1=CC=CC2=C1C (=C[NH]2) CCC (O) =OMolecular Formula:
C11H11NO2Molecular Weight:
189.21References & Citations:
[1]Wikoff WR, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009 Mar 10;106 (10) :3698-703.|[2]Reiter RJ, et al. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann N Y Acad Sci. 1998 Nov 20;854:410-24.|[3]de Mello VDet al. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Sci Rep. 2017 Apr 11;7:46337. doi: 10.1038/srep46337.Shipping Conditions:
Blue IceStorage Conditions:
4°C, sealed storage, away from light and moistureScientific Category:
Reference StandardsCAS Number:
830-96-6
